MapLight Therapeutics

MapLight Therapeutics is a clinical-stage biotechnology company dedicated to developing novel therapeutics for central nervous system disorders. Utilizing advanced technologies such as optogenetics, in vivo physiology, and spatial transcriptomics, the company aims to identify new drug targets and create effective treatments for psychiatric symptoms.